alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Year Cost Rate

Income 

Rate

Annual 

Balance

2005 11.13 12.72 1.59 320

2006 10.99 12.73 1.74 338

2007 10.93 12.74 1.81 356

2008 10.96 12.78 1.83 371

2009 11.08 12.77 1.69 385

2010 11.18 12.79 1.61 398

2011 11.33 12.84 1.51 409

2012 11.55 12.87 1.32 417

2013 11.79 12.90 1.11 423

2014 12.04 12.91 0.87 427

2015 12.30 12.93 0.63 430

2016 12.57 12.95 0.38 430

2017 12.85 12.97 0.11 428

2018 13.14 12.98 -0.15 425

2019 13.43 13.00 -0.42 421

2020 13.73 13.02 -0.71 415

2021 14.02 13.04 -0.98 407

2022 14.31 13.06 -1.26 398

2023 14.59 13.07 -1.52 388

2024 14.88 13.09 -1.79 377

2025 15.15 13.10 -2.05 365

2026 15.42 13.12 -2.30 351

2027 15.67 13.14 -2.54 336

2028 15.90 13.15 -2.75 321

2029 16.10 13.16 -2.93 305

2030 16.28 13.18 -3.10 289

2031 16.45 13.19 -3.26 272

2032 16.60 13.20 -3.40 254

2033 16.71 13.21 -3.51 237

2034 16.80 13.21 -3.59 218

2035 16.87 13.22 -3.65 200

2036 16.93 13.23 -3.70 181

2037 16.97 13.23 -3.74 162

2038 16.99 13.23 -3.76 142

2039 17.00 13.24 -3.76 123

2040 17.00 13.24 -3.77 102

2041 17.01 13.24 -3.77 82

2042 17.01 13.24 -3.77 61

2043 17.02 13.24 -3.77 40

2044 17.02 13.24 -3.78 19

2045 17.03 13.24 -3.78 ----

2046 17.04 13.25 -3.79 ----

2047 17.06 13.25 -3.81 ----

2048 17.07 13.25 -3.82 ----

2049 17.09 13.25 -3.84 ----

2050 17.12 13.25 -3.86 ----

2051 17.15 13.26 -3.89 ----

2052 17.18 13.26 -3.93 ----

2053 17.22 13.26 -3.96 ----

2054 17.27 13.27 -4.00 ----

2055 17.31 13.27 -4.04 ----

2056 17.36 13.27 -4.09 ----

2057 17.41 13.28 -4.14 ----

2058 17.46 13.28 -4.18 ----

2059 17.51 13.28 -4.23 ----

2060 17.56 13.29 -4.28 ----

2061 17.62 13.29 -4.33 ----

2062 17.67 13.29 -4.38 ----

2063 17.73 13.30 -4.43 ----

2064 17.79 13.30 -4.49 ----

2065 17.85 13.30 -4.54 ----

2066 17.91 13.31 -4.60 ----

2067 17.96 13.31 -4.65 ----

2068 18.02 13.32 -4.70 ----

2069 18.07 13.32 -4.75 ----

2070 18.12 13.32 -4.79 ----

2071 18.16 13.32 -4.84 ----

2072 18.21 13.33 -4.88 ----

2073 18.25 13.33 -4.92 ----

2074 18.29 13.33 -4.96 ----

2075 18.33 13.34 -5.00 ----

2076 18.38 13.34 -5.04 ----

2077 18.42 13.34 -5.08 ----

2078 18.46 13.34 -5.12 ----

2079 18.51 13.35 -5.16 ----

2080 18.55 13.35 -5.20 ----

Summarized Rates: OASDI

2005 Cost Rate Income Rate

Actuarial 

Balance

-2079 15.41% 13.85% -1.56% 0.37%

Office of the Chief Actuary, Social Security

Estimates based on Intermediate Assumptions of the 2005 Trustees Report January 4, 2006

Detailed Single Year Tables

Category of Change: Level of Monthly Benefits (PIA)

Change in 

Actuarial Balance

Proposed Provision: Reduce benefits by 3 percent for those newly eligible for benefits in 2006 and later

Expressed as a percentage of taxable payroll Trust Fund 

Ratio 

1-1-year
#### The People of the State of New York, Plaintiff, v Luis Nunez, Defendant.

Supreme Court, Criminal Term, New York County,

September 16, 1987

APPEARANCES OF COUNSEL

*J. Domanti*for defendant. *Robert H. Morgenthau, District Attorney (Andrew Torro*of counsel), for plaintiff.

OPINION OF THE COURT

Herman Cahn, J.

Defendant was indicted for criminal possession of a weapon *1063in the third degree. He moves, pursuant to CPL 210.20, for inspection of the Grand Jury minutes and dismissal of the indictment. Defendant’s motion is granted, and the indictment dismissed, with leave given the People to resubmit if they so desire.

The transcript of the Grand Jury proceedings reveals that during the presentation to the Grand Jury, a grand juror asked a question regarding the circumstances surrounding the search of defendant (and subsequent recovery of a gun). The Assistant District Attorney refused to answer the question: "That is an issue, if anything, to be litigated at a hearing prior to trial.”

The Assistant District Attorney was without authority to limit the questioning of the witness by the Grand Jury, thereby effectively controlling the information received by it before its vote.

The issue raised here is basically one, of the power and independence of the Grand Jury.

The Grand Jury’s power is derived from the NY Constitution, article I, § 6. As often said, the Grand Jury acts as a shield and as a sword, playing a critical investigatory role in the criminal justice system. Its primary function is to investigate crimes, although this power is not unlimited. *(Matter of Stem v Morgenthau,*62 NY2d 331.)

The Assistant District Attorney is one of the legal advisors to the Grand Jury (CPL 190.25 [6]). However, the Grand Jury has substantial powers independent of its legal advisors. Thus, it has the specific power to cause witnesses to be called. (CPL 190.50 [3].)

That the Legislature intended the Grand Jury to maintain independence is evidenced by the many sections governing Grand Jury proceedings. The Grand Jury determines for which crimes to indict a defendant, unlimited by those actually presented to it. (CPL 190.65 [2].) The Grand Jury may call any person believed by it to possess relevant information, and it may direct the District Attorney to call such person. (CPL 190.50 [3].) These powers would be illusory if a District Attorney were able to sift through a grand juror’s questions before presenting them to witnesses.

The court notes its awareness that the issue of admissibility is not litigated before the Grand Jury. (CPL 190.30 [5], [6].) However, that does not mean grand jurors are precluded from asking questions regarding the search and arrest of a defen*1064dant. Furthermore, the question asked in this case was most likely pointed towards a more fully developed understanding of the case, not at whether the police involved acted within their authority.

The Assistant District Attorney improperly foreclosed questioning on relevant information (CPL 190.30 [1]), and as such, was acting without authority. *(See, People v Rubin, 77*AD2d 578.)

Motion is granted, with leave given the People to resubmit.
8mi Route

S/F
## Fees for Administration of State Supplementary Payments

- Automatic Increases
-   
- Latest determination

| Fiscal year | Fee   |
|-------------|-------|
| 1994        | $1.67 |
| 1995        | 3.33  |
| 1996        | 5.00  |
| 1997        | 5.00  |
| 1998        | 6.20  |
| 1999        | 7.60  |
| 2000        | 7.80  |
| 2001        | 8.10  |
| 2002        | 8.50  |
| 2003        | 8.59  |
| 2004        | 8.77  |
| 2005        | 9.06  |
| 2006        | 9.29  |
| 2007        | 9.69  |
| 2008        | 9.95  |
| 2009        | 10.45 |
| 2010        | 10.45 |
| 2011        | 10.56 |
| 2012        | 10.94 |
| 2013        | 11.12 |
| 2014        | 11.32 |
| 2015        | 11.55 |
| 2016        | 11.56 |
| 2017        | 11.68 |
| 2018        | 11.87 |
| 2019        | 12.21 |
| 2020        | 12.41 |
| 2021        | 12.49 |
| 2022        | 13.16 |
| 2023        | 14.35 |
| 2024        | 14.78 |

Footer menu
**Exhibit
      32.2**




**CERTIFICATION**




I,
      Edwin
      F. Heinen, Chief Financial Officer of Glowpoint, Inc., a
      Delaware corporation (the "Company"), do hereby certify, in accordance with
      18
      U.S.C. Section 1350, as created pursuant to Section 906 of the Sarbanes-Oxley
      Act of 2002, that:




1)  The accompanying
      Quarterly Report on Form 10-Q of the Company for the quarter ended September
      30,
      2007 (the "Report") fully complies with the requirements of Section 13(a) or
      15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and




2)  The information
      contained in the Report fairly presents, in all material respects, the financial
      condition and results of operations of the Company .




Date:
      November 14, 2007




/s/ Edwin
                    F.
                    HeinenEdwin
                    F. HeinenChief
                    Financial Officer


A
      signed
      original of this written statement required by Section 906 of the Sarbanes-Oxley
      Act of 2002 (“Section 906”), or other document authenticating, acknowledging, or
      otherwise adopting the signature that appears in typed form within the
      electronic version of this written statement required by Section 906, has been
      provided to Glowpoint, Inc. and will be retained by Glowpoint, Inc. and
      furnished to the Securities and Exchange Commission or its staff upon
      request
Exhibit 31.2**CERTIFICATION OF CHIEF FINANCIAL OFFICER**  I, Richard A. Shields, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Washington BankingCompany; 2. Based on my knowledge, this report does not contain any untrue statement of amaterial fact or omit to state a material fact necessary to make the statements made,in light of the circumstances under which such statements were made, not misleadingwith respect to the period covered by this report; 3. Based on my knowledge, the financial statements, and other financialinformation included in this report, fairly present in all material respects thefinancial condition, results of operations and cash flows of the registrant as of, andfor, the periods presented in this report; 4. The registrant’s other certifying officer and I are responsible forestablishing and maintaining disclosure controls and procedures (as defined in ExchangeAct Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (asdefined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: (a) Designed such disclosure controls and procedures, or causedsuch disclosure controls and procedures to be designed under our supervision,to ensure that material information relating to the registrant, including itsconsolidated subsidiaries, is made known to us by others within those entities,particularly during the period in which this report is being prepared;  (b) Designed such internal control over financial reporting, orcaused such internal control over financial reporting to be designed under oursupervision, to provide reasonable assurance regarding the reliability offinancial reporting and the preparation of financial statements for externalpurposes in accordance with generally accepted accounting principles;  (c) Evaluated the effectiveness of the registrant’s disclosurecontrols and procedures and presented in this report our conclusions about theeffectiveness of the disclosure controls and procedures, as of the end of theperiod covered by this report based on such evaluation; and  (d) Disclosed in this report any change in the registrant’sinternal control over financial reporting that occurred during the registrant’smost recent fiscal quarter that has materially affected, or is reasonablylikely to materially affect, the registrant’s internal control over financialreporting; and5. The registrant’s other certifying officer and I have disclosed, based on ourmost recent evaluation of internal control over financial reporting, to theregistrant’s auditors and the audit committee of registrant’s board of directors (orpersons performing the equivalent function): (a) All significant deficiencies in the design or operation ofinternal control over financial reporting which are reasonably likely toadversely affect the registrant’s ability to record, process, summarize andreport financial information; and  (b) Any fraud, whether or not material, that involves management orother employees who have a significant role in the registrant’s internalcontrol over financial reporting.     Date: May 9, 2008 /s/ Richard A. Shields     Richard A. Shields    Chief Financial Officer
This disposition is not appropriate for publication and is not precedent *

except as provided by Ninth Circuit Rule 36-3.

NOT FOR PUBLICATION

UNITED STATES COURT OF APPEALS

 FOR THE NINTH CIRCUIT

MICHAEL SATTARI,

 Plaintiff - Appellant,

 v.

WASHINGTON MUTUAL, a

Washington corporation,

 Defendant - Appellee.

No. 10-17433

D.C. No. 2:09-cv-00768-KJD-PAL

MEMORANDUM*

Appeal from the United States District Court

for the District of Nevada

Kent J. Dawson, District Judge, Presiding

Argued and Submission Deferred August 10, 2011

Submitted ???, 2011

San Francisco, California

Before: KOZINSKI, Chief Judge, O’SCANNLAIN and GRABER, Circuit 

Judges.

Sattari mistakenly referenced California statutes rather than Nevada statutes

throughout his complaint. Because Sattari was a pro se litigant when he wrote the

complaint, we construe it liberally to infer that he meant to reference Nevada law. 

FILED

DEC 23 2011

MOLLY C. DWYER, CLERK

U.S. COURT OF APPEALS
page 2

See Erickson v. Pardus, 551 U.S. 89, 94 (2007) (per curiam) (“[A] pro se

complaint, however inartfully pleaded, must be held to less stringent standards than

formal pleadings drafted by lawyers.”) (internal quotation marks omitted). 

Sattari claims the bank engaged in unfair business practices. Under the

Nevada Deceptive Trade Practices Act (NDTPA), “[a]n action may be brought by

any person who is a victim of consumer fraud.” Nev. Rev. Stat. § 41.600(1). A

claim under the NDTPA requires a “victim of consumer fraud to prove that (1) an

act of consumer fraud by the defendant (2) caused (3) damage to the plaintiff.” 

Picus v. Wal-Mart Stores, Inc., 256 F.R.D. 651, 658 (D. Nev. 2009) (order). 

Consumer fraud encompasses deceptive practices, such as “[k]nowingly mak[ing

a] . . . false representation in a transaction.” Nev. Rev. Stat. § 598.0915(15). 

Sattari does not raise a genuine issue of material fact that would show that the bank

made a false representation, so this claim fails. 

Sattari mentions wrongful foreclosure and emotional distress in his brief, but

doesn’t “specifically and distinctly” argue these claims. Miller v. Fairchild Indus.,

Inc., 797 F.2d 727, 738 (9th Cir. 1986) (“The Court of Appeals will not ordinarily

consider matters on appeal that are not specifically and distinctly argued in

appellant’s opening brief.”). We require a brief to contain “appellant’s contentions

and the reasons for them, with citations to the authorities and parts of the record on
page 3

which the appellant relies.” Fed. R. App. P. 28(a)(9)(A). Sattari provides neither

any argument nor supporting authority. Therefore, he has waived any claims based

on wrongful foreclosure and emotional distress. 

AFFIRMED.
```

[Congressional Bills 117th Congress]
[From the U.S. Government Publishing Office]
[S. 353 Introduced in Senate (IS)]

<DOC>

117th CONGRESS
  1st Session
                                 S. 353

 To incentivize banning of chokeholds and carotid holds, and for other 
                               purposes.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                           February 22, 2021

Ms. Klobuchar (for herself, Ms. Smith, and Mrs. Gillibrand) introduced 
the following bill; which was read twice and referred to the Committee 
                            on the Judiciary

_______________________________________________________________________

                                 A BILL

 
 To incentivize banning of chokeholds and carotid holds, and for other 
                               purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``End Police Use of Chokeholds Act of 
2021''.

SEC. 2. INCENTIVIZING BANNING OF CHOKEHOLDS AND CAROTID HOLDS.

    (a) Definitions.--In this section:
            (1) Byrne grant program.--The term ``Byrne grant program'' 
        means any grant program under subpart 1 of part E of title I of 
        the Omnibus Crime Control and Safe Streets Act of 1968 (34 
        U.S.C. 10151 et seq.), without regard to whether the funds are 
        characterized as being made available under the Edward Byrne 
        Memorial State and Local Law Enforcement Assistance Programs, 
        the Local Government Law Enforcement Block Grants Program, the 
        Edward Byrne Memorial Justice Assistance Grant Program, or 
        otherwise.
            (2) Chokehold or carotid hold.--The term ``chokehold or 
        carotid hold'' means the application of any pressure to the 
        throat or windpipe, the use of maneuvers that restrict blood or 
        oxygen flow to the brain, or carotid artery restraints that 
        prevent or hinder breathing or reduce intake of air of an 
        individual.
            (3) COPS grant program.--The term ``COPS grant program'' 
        means the grant program authorized under section 1701 of title 
        I of the Omnibus Crime Control and Safe Streets Act of 1968 (34 
        U.S.C. 10381).
    (b) Limitation on Eligibility for Funds.--Beginning in the first 
fiscal year beginning after the date of enactment of this Act, a State 
or local jurisdiction may not receive funds under the Byrne grant 
program or the COPS grant program for a fiscal year if, on the day 
before the first day of the fiscal year, the State or other 
jurisdiction does not have in effect a law that prohibits law 
enforcement officers in the State or other jurisdiction from using a 
chokehold or carotid hold.
                                 <all>
```
[Federal Register Volume 81, Number 23 (Thursday, February 4, 2016)]
[Notices]
[Page 6028]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-02050]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Allergy, Immunology, and Transplantation 
Research Committee.
    Date: February 24-25, 2016.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda North Marriott Hotel & Conference Center, 
Montgomery County Conference Center Facility, White Oak B Room, 5701 
Marinelli Road, North Bethesda, MD 20852.
    Contact Person: James T. Snyder, Ph.D., Scientific Review 
Officer, Scientific Review Program, Division of Extramural 
Activities/Room 3G31B, National Institutes of Health, NIAID, 5601 
Fishers Lane MSC 9834, Bethesda, MD 20892-9834, (240) 669-5060, 
<a href="/cdn-cgi/l/email-protection#abc1cac6ced885d8c5d2cfced9ebc5c2c385ccc4dd"><span class="__cf_email__" data-cfemail="8ce6ede1e9ffa2ffe2f5e8e9fecce2e5e4a2ebe3fa">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)


    Dated: January 29, 2016.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-02050 Filed 2-3-16; 8:45 am]
 BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Exhibit 4.2


 


 



Consent of Independent Registered Public
Accounting Firm


We have issued our report
dated December 15, 2022, with respect to the financial statement of Advisors Disciplined Trust 2144 contained in Amendment No. 1 to the
Registration Statement on Form S-6 (File No. 333-267945) and related Prospectus. We consent to the use of the aforementioned report in
the Registration Statement and Prospectus, and to the use of our name as it appears under the caption “Experts”.


 


/s/ Grant
Thornton LLP


 


Chicago, Illinois


December 15, 2022
|Exhibit 32.1



CERTIFICATION PURSUANT
TO 18 U.S.C. SECTION 1350,AS ADOPTED PURSUANT TO SECTION 906 OF
THE SARBANES-OXLEY ACT OF 2002


In
connection with the annual report on Form 10-K of Palomar Medical Technologies, Inc.
(Palomar) for the fiscal year ended December 31, 2008 as filed with the
Securities and Exchange Commission on the date hereof (the Report), I, Joseph
P. Caruso, as Chief Executive Officer of Palomar, and Paul S. Weiner, as Chief Financial
Officer of Palomar, hereby certify, pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to
ss. 906 of the Sarbanes-Oxley Act of 2002, that:
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|1) |  | The Report fully complies with the requirements of Section 13(a) or
               15(d) of the Securities Exchange Act of 1934; and
|-- |  | ------------------------------------------------------------------------------------------------------------------------------------

|2) |  | The information contained in the Report fairly presents, in all material
               respects, the financial condition and results of operations of the Company.
|-- |  | -------------------------------------------------------------------------------------------------------------------------------------------------------------------

| |                                              
| | ---------------------------------------------
| | By:/s/ Joseph P. Caruso                      
| | Name: Joseph P. Caruso                       
| | Title:  Chief Executive Officer and President
| |                                              
| | Date:   March 5, 2009                        

| |                               
| | ------------------------------
| | By:/s/ Paul S. Weiner         
| | Name: Paul S. Weiner          
| | Title: Chief Financial Officer
| |                               
| | Date: March 5, 2009           

|
|
[Federal Register Volume 81, Number 23 (Thursday, February 4, 2016)]
[Notices]
[Page 6038]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-02095]


-----------------------------------------------------------------------

DEPARTMENT OF THE INTERIOR

Bureau of Land Management

[LLNV912000 L13400000.PQ0000 LXSS006F0000; MO#4500090018]


Notice of Public Meeting: Bureau of Land Management Nevada 
Resource Advisory Councils; Postponement

    In the notice document published Monday, February 1, 2016 (81 FR 
5132), a public meeting of the Bureau of Land Management Nevada 
Resource Advisory Councils was announced.
    The BLM Nevada Resource Advisory Council meeting scheduled for 
February 10-11, 2016 has been postponed until the outstanding member 
appointments have been finalized. A new notice will be published when 
the dates have been decided.

Rudy Evenson,
Deputy Chief, Office of Communications.
[FR Doc. 2016-02095 Filed 2-3-16; 8:45 am]
 BILLING CODE 4310-HC-P